サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1434238

血液培養検査市場：製品、技術、用途、エンドユーザー別-2023-2030年の世界予測

Blood Culture Test Market by Product (Consumable, Instrument, Software and Services), Technology (Culture-Based Technology, Molecular Technology, Proteomics Technology), Application, End User - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 189 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
血液培養検査市場：製品、技術、用途、エンドユーザー別-2023-2030年の世界予測
出版日: 2024年01月12日
発行: 360iResearch
ページ情報: 英文 189 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

血液培養検査の市場規模は2022年に39億9,000万米ドルと推定され、2023年には42億3,000万米ドルに達し、 CAGR 6.17%で2030年までに64億4,000万米ドルに達すると予想されています。

世界の血液培養検査市場

主な市場の統計
基準年[2022] 39億9,000万米ドル
推定年[2023] 42億3,000万米ドル
予測年[2030] 64億4,000万米ドル
CAGR（%） 6.17%
血液培養検査市場-IMG1

血液培養検査は、血液中の細菌や真菌などの微生物の存在を検出するために利用される臨床診断手順です。 血液培養検査は、ヘルスケア提供者が患者が敗血症や菌血症などの全身感染症に罹患していると疑う場合に注文されます。この検査には、患者から血液サンプルを採取し、それを制御された環境で培養して、存在する微生物の増殖を促進することが含まれます。 血液培養検査は現代医学において感染症を管理するための重要なツールであり、病院や参考研究室で日常的に実行されています。高齢者人口の増加に伴う血流感染症と敗血症の有病率の上昇により、血液培養検査の必要性が高まっています。さらに、ヘルスケアインフラと診断技術の改善と、早期かつ迅速な診断への注目の高まりにより、血液培養検査のアクセシビリティと使用率が増加しました。ただし、高度な血液培養検査技術に関連するコストが高いため、市場の成長が制限される可能性があります。それにもかかわらず、結果が出るまでの時間を短縮するための迅速な診断検査の開発と、病原体を正確に特定するための分子診断の進歩により、市場にとって好機となる情勢が生まれる可能性があります。

地域の洞察

南北アメリカにおける血液培養検査の市場は大幅に成長しており、米国は血液培養検査製品の消費と生産の両方に大きく貢献しています。敗血症の高い発生率、確立されたヘルスケアインフラ、確立された市場プレーヤーの存在などの要因が、この地域の成長に貢献しています。自動血液培養システムの採用と迅速な診断ツールの重要性の高まりにより、需要がさらに高まっています。 欧州・中東・アフリカ地域では、国ごとに経済状況やヘルスケア制度が異なるため、血液培養検査の市場情勢は多様です。欧州は市場が大幅に成長しており、ヘルスケア現場での感染対策に重点が置かれています。一方、中東とアフリカは新興市場であり、ヘルスケアインフラへの投資が増加しています。欧州市場は、強力なヘルスケア政策、高額なヘルスケア支出、世界の診断会社の存在によって恩恵を受けています。疾病監視プログラムや抗菌薬耐性を抑制する取り組みも、この地域の市場成長に貢献しています。アジア太平洋地域では、ヘルスケア施設の急速な改善、健康意識の高まり、政府のヘルスケア支出の増加により、血液培養検査市場が急速な成長率を示すと予想されています。膨大な人口基盤、感染症の蔓延、病院や臨床診断研究所の数の増加が、アジア太平洋市場の成長にさらに貢献しています。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは、血液培養検査市場を評価する上で極めて重要です。ビジネス戦略と製品満足度に関連する主要な指標を調査し、ベンダーの包括的な評価を提供します。この詳細な分析により、ユーザーは十分な情報に基づいて要件に合わせた意思決定を行うことができます。評価に基づいて、ベンダーはさまざまな成功レベルを表す4つの異なる象限（Forefront（F）、Pathfinder（P）、Niche（N）、またはVital（V））に分類されます。

市場シェア分析

マーケットシェア分析は、血液培養検査市場のベンダーの現状を洞察力に富んだ詳細な調査で提供する包括的なツールです。全体的な収益、顧客ベース、その他の主要な指標の観点からベンダーの貢献を注意深く比較および分析することで、企業が自社のパフォーマンスと市場シェアを争う際に直面する課題をより深く理解できるようになります。さらに、この分析は、調査対象の基準年期間にわたって観察された蓄積、断片化の優位性、融合特性などの要因を含む、セクターの競争特性に関する貴重な洞察を提供します。この詳細レベルの拡張により、ベンダーはより多くの情報に基づいた意思決定を行い、市場での競争力を獲得するための効果的な戦略を考案できるようになります。

このレポートは、次の側面に関する貴重な洞察を提供します。

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を示します。

2-市場の発掘：収益性の高い新興市場を深く掘り下げ、成熟した市場セグメント全体への浸透を分析します。

3-市場の多様性：新製品の発売、未開発の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制当局の承認、特許情勢、製造能力の徹底的な評価を実施します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関するインテリジェントな洞察を提供します。

このレポートでは、次のような重要な質問が取り上げられています。

1-血液培養検査市場の市場規模と予測は？

2-血液培養検査市場の予測期間中に投資を検討すべき製品、セグメント、アプリケーション、および分野は？

3-血液培養検査市場における技術動向と規制の枠組みは？

4-血液培養検査市場における主要ベンダーの市場シェアは？

5-血液培養検査市場への参入に適したモードと戦略的動きは？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 血流感染症と感染症の蔓延によるポイントオブケアおよび迅速な診断検査の必要性
      • 特に診断の向上を目的とした公的および民間のヘルスケア費の増加
      • 臨床および研究室の償還ポリシーに伴う政府の支援と承認
    • 抑制要因
      • 汚染された血液培養に関連する潜在的なリスク
    • 機会
      • 診断検査および診断方法の進歩における新たな研究開発（R&D）活動
      • 自動血液培養検査の導入が増加
    • 課題
      • 血液培養の開発と生産における厳格な政府規範
  • 市場セグメンテーション分析
    • 製品：血液培養データの分析とレポート作成の自動化を強化するソフトウェアの継続的な進歩
    • 技術：病原体の迅速かつ特異的な検出により、分子テクノロジーの重要性が高まる
    • 用途：血液培養検査の利用を促進する血流感染症の蔓延
    • エンドユーザー：病原体検出の特異性と感度を高めるために、学術調査機関による血液培養検査の利用が増加
  • 市場動向分析
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 血液培養検査市場：製品別

  • 消耗品
  • 機器
  • ソフトウェアとサービス

第7章 血液培養検査市場：技術別

  • カルチャーベース技術
  • 分子技術
  • プロテオミクス技術

第8章 血液培養検査市場：用途別

  • 菌血症
  • 真菌症
  • マイコバクテリアの検出

第9章 血液培養検査市場：エンドユーザー別

  • 学術調査機関
  • 病院検査室
  • リファレンスラボ

第10章 南北アメリカの血液培養検査市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の血液培養検査市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの血液培養検査市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析
    • 契約、コラボレーション、パートナーシップ
    • 新製品発売と機能強化

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Abbott Laboratories
    • Anaerobe Systems, Inc.
    • Autobio Diagnostics Co., Ltd.
    • Becton, Dickinson and Company
    • BINDER GmbH
    • Biobase Biodusty（Shandong）, Co., Ltd.
    • Biomerieux SA
    • Bruker Corporation
    • Danaher Corporation
    • Devyser AB
    • Eli Lilly and Company
    • F. Hoffmann-La Roche Ltd.
    • HiMedia Laboratories Pvt. Ltd.
    • Juno Diagnostics, Inc.
    • Neogen Corporation
    • Novartis AG
    • OpGen, Inc.
    • Scenker Biological Technology Co., Ltd.
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Siemens Healthineers AG
    • T2 Biosystems, Inc.
    • Terumo Corporation
    • Thermo Fisher Scientific, Inc.
    • ZeptoMetrix Corporation
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. BLOOD CULTURE TEST MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD CULTURE TEST MARKET SIZE, 2022 VS 2030
  • FIGURE 3. BLOOD CULTURE TEST MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. BLOOD CULTURE TEST MARKET DYNAMICS
  • FIGURE 7. BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 8. BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 10. BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 12. BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 14. BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 16. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 18. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 23. BLOOD CULTURE TEST MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 24. BLOOD CULTURE TEST MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. BLOOD CULTURE TEST MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. BLOOD CULTURE TEST MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. BLOOD CULTURE TEST MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 10. BLOOD CULTURE TEST MARKET SIZE, BY CULTURE-BASED TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. BLOOD CULTURE TEST MARKET SIZE, BY PROTEOMICS TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. BLOOD CULTURE TEST MARKET SIZE, BY BACTEREMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. BLOOD CULTURE TEST MARKET SIZE, BY FUNGEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. BLOOD CULTURE TEST MARKET SIZE, BY MYCOBACTERIAL DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. BLOOD CULTURE TEST MARKET SIZE, BY ACADEMIC RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. BLOOD CULTURE TEST MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. BLOOD CULTURE TEST MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. BLOOD CULTURE TEST MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 190. BLOOD CULTURE TEST MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 191. BLOOD CULTURE TEST MARKET LICENSE & PRICING
目次
Product Code: MRR-035DA3C63738

[189 Pages Report] The Blood Culture Test Market size was estimated at USD 3.99 billion in 2022 and expected to reach USD 4.23 billion in 2023, at a CAGR 6.17% to reach USD 6.44 billion by 2030.

Global Blood Culture Test Market

KEY MARKET STATISTICS
Base Year [2022] USD 3.99 billion
Estimated Year [2023] USD 4.23 billion
Forecast Year [2030] USD 6.44 billion
CAGR (%) 6.17%
Blood Culture Test Market - IMG1

The blood culture test is a clinical diagnostic procedure utilized to detect the presence of microorganisms, such as bacteria or fungi, in the blood. A blood culture test is ordered when a healthcare provider suspects that a patient is suffering from a systemic infection, such as septicemia or bacteremia. This test includes drawing a blood sample from the patient and incubating it in a controlled environment to promote the growth of any microorganisms present. The blood culture test is a vital tool in modern medicine for managing infectious diseases and is routinely performed in hospitals and reference laboratories. The rising prevalence of bloodstream infections and sepsis with an increasing aging population drives the need for blood culture tests. Moreover, improvements in healthcare infrastructure and diagnostic technologies coupled with an increasing focus on early and rapid diagnosis have increased the accessibility and use of blood culture tests. However, the high cost associated with advanced blood culture testing technologies may restrict the market growth. Nevertheless, the development of rapid diagnostic tests to decrease the time-to-results and advancements in molecular diagnostics for precise pathogen identification may create an opportunistic landscape for the market.

Regional Insights

The market for blood culture tests in the Americas is growing significantly, with the United States contributing majorly to both the consumption and production of blood culture test products. Factors such as a high incidence rate of sepsis, well-established healthcare infrastructure, and the presence of established market players contribute to the growth in this region. The adoption of automated blood culture systems and the growing importance of rapid diagnostic tools are driving the demand further. The EMEA region exhibits a diverse market landscape for blood culture tests owing to variances in economic conditions and healthcare systems across countries. Europe represents a significant growth of the market, with a strong emphasis on infection control measures in healthcare settings. The Middle East and Africa, on the other hand, are emerging markets with increasing investments in healthcare infrastructure. The European market benefits from robust healthcare policies, high healthcare expenditure, and the presence of global diagnostic companies. Disease surveillance programs and initiatives to curb antimicrobial resistance are also aiding in market growth in this region. The Asia-Pacific region is anticipated to exhibit a rapid growth rate in the blood culture test market attributed to rapidly improving healthcare facilities, growing health awareness, and increased government healthcare expenditures. The vast population base, the increasing prevalence of infectious diseases, and the rising number of hospitals and clinical diagnostic laboratories are further contributing to the growth of the market in the APAC.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Blood Culture Test Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Blood Culture Test Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Blood Culture Test Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Anaerobe Systems, Inc., Autobio Diagnostics Co., Ltd., Becton, Dickinson and Company, BINDER GmbH, Biobase Biodusty(Shandong), Co., Ltd., Biomerieux SA, Bruker Corporation, Danaher Corporation, Devyser AB, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., HiMedia Laboratories Pvt. Ltd., Juno Diagnostics, Inc., Neogen Corporation, Novartis AG, OpGen, Inc., Scenker Biological Technology Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers AG, T2 Biosystems, Inc., Terumo Corporation, Thermo Fisher Scientific, Inc., and ZeptoMetrix Corporation.

Market Segmentation & Coverage

This research report categorizes the Blood Culture Test Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Consumable
    • Instrument
    • Software and Services
  • Technology
    • Culture-Based Technology
    • Molecular Technology
    • Proteomics Technology
  • Application
    • Bacteremia
    • Fungemia
    • Mycobacterial Detection
  • End User
    • Academic Research Laboratories
    • Hospital Laboratories
    • Reference Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Blood Culture Test Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Blood Culture Test Market?

3. What are the technology trends and regulatory frameworks in the Blood Culture Test Market?

4. What is the market share of the leading vendors in the Blood Culture Test Market?

5. Which modes and strategic moves are suitable for entering the Blood Culture Test Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Blood Culture Test Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need for Point-of-Care and Rapid Diagnostic Tests Owing to the Growing Prevalence of Bloodstream Infections and Infectious Diseases
      • 5.1.1.2. Rising Public and Private Healthcare Expenditure Specifically for the Improved Diagnosis
      • 5.1.1.3. Government Support and Approval Along with Clinical and Lab Reimbursement Policies
    • 5.1.2. Restraints
      • 5.1.2.1. Potential Risk Associated with Contaminated Blood Culture
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Research and Development (R&D) Activities in the Advancement of Diagnostic Tests and Methods
      • 5.1.3.2. Rising Adoption of Automated Blood Culture Tests
    • 5.1.4. Challenges
      • 5.1.4.1. Strict Government Norms in the Development and Production of Blood Cultures
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Ongoing advancement in the softwares to enhance automation in blood culture data analysis and reporting.
    • 5.2.2. Technology: Growing significance of molecular technology due to its rapid and specific detection of pathogens
    • 5.2.3. Application: Increasing prevalence of bloodstream infections driving the utilization of blood culture test
    • 5.2.4. End User: Rising utilization of blood culture test by academic research laboratories for to enhance the specificity and sensitivity of pathogen detection
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of COVID-19
  • 5.5. Cumulative Impact of Russia-Ukraine Conflict
  • 5.6. Cumulative Impact of High Inflation
  • 5.7. Porter's Five Forces Analysis
    • 5.7.1. Threat of New Entrants
    • 5.7.2. Threat of Substitutes
    • 5.7.3. Bargaining Power of Customers
    • 5.7.4. Bargaining Power of Suppliers
    • 5.7.5. Industry Rivalry
  • 5.8. Value Chain & Critical Path Analysis
  • 5.9. Regulatory Framework
  • 5.10. Client Customization

6. Blood Culture Test Market, by Product

  • 6.1. Introduction
  • 6.2. Consumable
  • 6.3. Instrument
  • 6.4. Software and Services

7. Blood Culture Test Market, by Technology

  • 7.1. Introduction
  • 7.2. Culture-Based Technology
  • 7.3. Molecular Technology
  • 7.4. Proteomics Technology

8. Blood Culture Test Market, by Application

  • 8.1. Introduction
  • 8.2. Bacteremia
  • 8.3. Fungemia
  • 8.4. Mycobacterial Detection

9. Blood Culture Test Market, by End User

  • 9.1. Introduction
  • 9.2. Academic Research Laboratories
  • 9.3. Hospital Laboratories
  • 9.4. Reference Laboratories

10. Americas Blood Culture Test Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Blood Culture Test Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Blood Culture Test Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Agreement, Collaboration, & Partnership
      • 13.3.1.1. Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States
      • 13.3.1.2. BD, Magnolia Medical Technologies Announce Commercial Collaboration to Help Reduce Blood Culture Contamination and Improve Testing Accuracy
    • 13.3.2. New Product Launch & Enhancement
      • 13.3.2.1. Accelerate Diagnostics Launches Arc System for Use in Blood Culture Test

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Abbott Laboratories
    • 14.1.2. Anaerobe Systems, Inc.
    • 14.1.3. Autobio Diagnostics Co., Ltd.
    • 14.1.4. Becton, Dickinson and Company
    • 14.1.5. BINDER GmbH
    • 14.1.6. Biobase Biodusty(Shandong), Co., Ltd.
    • 14.1.7. Biomerieux SA
    • 14.1.8. Bruker Corporation
    • 14.1.9. Danaher Corporation
    • 14.1.10. Devyser AB
    • 14.1.11. Eli Lilly and Company
    • 14.1.12. F. Hoffmann-La Roche Ltd.
    • 14.1.13. HiMedia Laboratories Pvt. Ltd.
    • 14.1.14. Juno Diagnostics, Inc.
    • 14.1.15. Neogen Corporation
    • 14.1.16. Novartis AG
    • 14.1.17. OpGen, Inc.
    • 14.1.18. Scenker Biological Technology Co., Ltd.
    • 14.1.19. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 14.1.20. Siemens Healthineers AG
    • 14.1.21. T2 Biosystems, Inc.
    • 14.1.22. Terumo Corporation
    • 14.1.23. Thermo Fisher Scientific, Inc.
    • 14.1.24. ZeptoMetrix Corporation
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing